Recordati S.p.A. | |
Stock Exchange | Electronic Share Market |
EPS |
EUR1.46 |
Market Cap |
EUR6.29 B |
Shares Outstanding |
209.13 M |
Public Float |
94.58 M |
Recordati S.p.A. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Address |
Via Matteo Civitali, 1 Milan Milan 20148 Italy |
Employees | - |
Website | http://www.recordati.it |
Updated | 09/14/2018 |
Recordati SpA engages in the research, development, manufacturing and marketing of pharmaceuticals. It operates through two segments: Pharmaceutical and Rare Diseases. The Pharmaceutical segment offers prescription and over-the-counter products as well as chemical syntheses, intermediates, and active ingredients for its proprietary and licensed brands. |